Hi, Shrewd!        Login  
Shrewd'm.com 
A merry & shrewd investing community
Best Of BRK.A | Best Of | Favourites & Replies | All Boards | Post of the Week! | How To Invest
Search BRK.A
Shrewd'm.com Merry shrewd investors
Best Of BRK.A | Best Of | Favourites & Replies | All Boards | Post of the Week! | How To Invest
Search BRK.A


Stocks A to Z / Stocks B / Berkshire Hathaway (BRK.A)
Unthreaded | Threaded | Whole Thread (15) |
Author: DTB 🐝  😊 😞
Number: of 19824 
Subject: Re: OxyChem Deal: , another opinion,
Date: 10/08/25 4:16 PM
Post New | Post Reply | Report Post | Recommend It!
No. of Recommendations: 8
Reducing debt at OXY provides direct value to BRK. BRK uses $9.7B cash and gets the chemical business worth supposedly >$10B and 32.7% of $6.5B debt pay down and the same percentage of $9.7 - $6.5B = $3.2B of cash at OXY.

So net advantage to BRK:
>$10B chemical business
$2.12B OXY debt pay down
$3.2B OXY cash infusion
———
Total benefit $15.32B



There are 2 problems with this:
(i) Since BRK only owns the chemical business once, it loses the portion of OXY's chemical business that it already owned through OXY. In other words, we need an additional line:
-$3.27B diminished value of OXY, which no longer owns that $10B chemical business.
(ii) BRK only gets the benefit of 32.7% of the $3.2B of OXY cash increase, so that line should be:
$1.05B OXY cash increase

That means that Berkshire gets:
$10B chemical business
$2.12B OXY debt pay down
$1.05B OXY cash infusion
-$3.27B in value of the chemical business it previously owned through OXY

Total benefit $9.9B - which makes more intuitive sense anyways.

DTB

Post New | Post Reply | Report Post | Recommend It!
Print the post
Unthreaded | Threaded | Whole Thread (15) |


Announcements
Berkshire Hathaway FAQ
Contact Shrewd'm
Contact the developer of these message boards.

Best Of BRK.A | Best Of | Favourites & Replies | All Boards | Followed Shrewds